What You Should Know:
Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today announced expanded capabilities designed to help employers and health plans manage rising demand for anti-obesity medication such as glucagon-like peptide 1 (GLP-1) agonists and support safe, sustainable weight loss and cardiometabolic health improvement for members.New features include helping plan sponsors and pharmacy benefit managers manage and optimize the growing complexity and
Read More
GLP-1
WeightWatchers Launches First-Of-Its-Kind GLP-1 Program + WeightWatchers Clinic
What You Should Know:
- WeightWatchers launches two new offerings to further support individuals on their journeys to better health: the WeightWatchers GLP-1 Program and WeightWatchers Clinic integration within the WeightWatchers App.
- By focusing on personalization, scientific evidence, and comprehensive support, WW empowers individuals to take control of their weight health and achieve lasting results.
WeightWatchers GLP-1 Program
This program addresses the unique needs of
Read More
